TrialCirculation research2017

PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.

Arshed A Quyyumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.